Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Medical Marijuana. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Medical Marijuana's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medical Marijuana has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Medical Marijuana's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Medical Marijuana's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare Medical Marijuana's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if Medical Marijuana is high growth as no earnings estimate data is available.
Unable to determine if Medical Marijuana is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Medical Marijuana's filings and announcements here.
Medical Marijuana's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Medical Marijuana's finances.
The net worth of a company is the difference between its assets and liabilities.
Medical Marijuana is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Medical Marijuana's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Medical Marijuana's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Debt is covered by short term assets, assets are 1.3x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
Dr. Stuart W. Titus, Ph.D., has been the Chief Executive Officer and President of Medical Marijuana, Inc. since March 18, 2015. Dr. Titus is the Chairman of the board of Director and Acting Chief Financial Officer of Medical Marijuana Inc. He is the Co-founder and serves as President of General Hemp, LLC which with Titus at the helm has managed the emergence and growth of several other companies, including CannaVest, KannaLife Sciences Inc. (Board Member) and KannaWAY. Dr. Titus is an Industry Icon and Innovator, having been involved in all aspects of the medical marijuana and industrial hemp industries, Dr. Titus was the number seven investor in Medical Marijuana, Inc., having invested in its seed financing. Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses. Dr. Titus' expertise in finance was forged on Wall Street, where he worked as a bond trader for 11 years, managing a trading and underwriting department as a Vice President for CS First Boston Corp. Dr. Titus also has a unique background in health. Post-Wall Street, he worked as a British Physiotherapist for over 15 years, having run clinics that specialized in integrative pain management and injury rehabilitation, which treated over 40,000 patients. Dr. Titus is active in the medical community with specific interest in electro-physiotherapy as well as in anti-aging medicine. He holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine. Dr. Titus has unique first-hand experience with hemp oil products as nutritional supplements, having found great relief from Lyme's disease symptoms after beginning a regimen of high-concentration CBD therapeutic hemp products. He has been a Director of Medical Marijuana, Inc. since March 18, 2015. Dr. Titus is a graduate of Rollins College in Winter Park, Florida, where he majored in Economics and minored in Business Administration. He earned his Ph.D. degree from the Open International University, which is a World Health Organization (WHO) chartered affiliate.
Insufficient data for Stuart to compare compensation growth.
Insufficient data for Stuart to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure
Average tenure of the
management team in years:
The average tenure for the Medical Marijuana management team is less than 2 years, this suggests a new team.
Chairman of the Board
COO & Executive VP
Vice President of Data & Technology
Director of Business Development
Chief Operating Officer of Red Dice Holdings
Member of Advisory Board and Chief Executive Officer of Canchew Biotechnologies
President of Latin America
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the Medical Marijuana board of directors is about average.
Board of Directors
Member of Advisory Board and Chief Executive Officer of Canchew Biotechnologies
Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.